Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
13.44
+0.13 (0.98%)
At close: Aug 7, 2026, 4:00 PM EDT
13.25
-0.19 (-1.41%)
After-hours: Aug 7, 2026, 7:59 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $769.87 million as of August 7, 2026. Its market cap has increased by 217.44% in one year.
Market Cap
769.87M
Enterprise Value
651.89M
1-Year Change
217.44%
Ranking
Category
Stock Price
$13.44
ChartMarket Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has increased from $110.17M to $769.87M, an increase of 598.78%. That is a compound annual growth rate of 5.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 769.87M | 55.67% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 804.11M |
| Monopar Therapeutics | 798.56M |
| DBV Technologies | 795.72M |
| Pharming Group | 785.51M |
| Bright Minds Biosciences | 781.58M |
| Candel Therapeutics | 775.93M |
| Oculis Holding AG | 765.72M |
| CytomX Therapeutics | 753.93M |